CompletedPhase 1NCT00111553

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis

Studying Leishmaniasis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Access to Advanced Health Institute (AAHI)
Principal Investigator
Evaldo Nascimento, MD
Federal University of Minas Gerais
Intervention
Leish-111f + MPL-SE vaccine(biological)
Enrollment
45 enrolled
Eligibility
18-60 years · All sexes
Timeline
20042006

Study locations (2)

Collaborators

Bill and Melinda Gates Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00111553 on ClinicalTrials.gov

Other trials for Leishmaniasis

Additional recruiting or active studies for the same condition.

See all trials for Leishmaniasis

← Back to all trials